Potassium Iodide

Overview

Saturated solution of Potassium Iodide (SSKI) is used pharmaceutically for emergency use in patients experiencing acute symptoms of severe hyperthyroidism (also known as thyroid storm or thyrotoxic crisis). SSKI can also be used for radioiodine-contamination emergencies or in preparation of thyrotoxic patients for thyroidectomy.

Indication

Potassium Iodide is oral antithyroid agent used in the prevention of radioactive iodine uptake into the thyroid gland during a nuclear radiation emergency. Potassium Iodide may be used as an adjunct to other antithyroid agents in the treatment of hyperthyroidism and thyrotoxicosis and preoperatively to induce thyroid involution.

Associated Conditions

Acute radiation sickness
Folate deficiency
Goitre
Hypothyroidism
Iodine Deficiency
Iron Deficiency (ID)
Thyroid Cancer

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Measurement of Iodolipids in the Thyroid Gland and Other Biological Samples	2022/11/28	NCT05628506	Not Applicable	Not yet recruiting	Prof. Gerasimos Sykiotis
Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects	2020/12/28	NCT04686006	N/A	Completed	Kyushu University
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma	2018/08/28	NCT03649438	N/A	NO_LONGER_AVAILABLE	University of Texas Southwestern Medical Center
MIBG With Dinutuximab +/- Vorinostat	2017/11/06	NCT03332667	Phase 1	Completed	New Approaches to Neuroblastoma Therapy Consortium
Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease	2009/07/24	NCT00946296	Phase 4	Completed	University of Massachusetts, Worcester
Preventing Lack of Iodine During Pregnancy	2006/09/22	NCT00379535	Phase 3	Terminated	University Hospital, Toulouse

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Vitafol Fe Plus	Exeltis USA, Inc.	0642-7473	ORAL	150 ug in 1 1	2/14/2023
Lugols Strong Iodine	CooperSurgical, Inc.	59365-6064	TOPICAL	0.100 g in 1 mL	4/15/2020
Prenate Essential	Avion Pharmaceuticals, LLC	75854-313	ORAL	150 ug in 1 1	1/7/2021
PRENATE Enhance	Avion Pharmaceuticals, LLC	75854-309	ORAL	150 mg in 1 1	1/7/2021
Bestmade Natural Products Potassium Iodide (Kali Iod)	Bestmade Natural Products	82969-1033	ORAL	6 [hp_X] in 6 [hp_X]	5/26/2025
Prenate Pixie	Avion Pharmaceuticals, LLC	75854-316	ORAL	150 ug in 1 1	1/7/2021
Prenatrix	PureTek Corporation	59088-166	ORAL	150 ug in 1 1	2/8/2023
Zintrexyl-C	PureTek Corporation	59088-180	ORAL	25 ug in 1 1	1/11/2023
Folitin-Z	PureTek Corporation	59088-181	ORAL	25 ug in 1 1	1/11/2023
Prenate Elite	Avion Pharmaceuticals, LLC	75854-314	ORAL	150 ug in 1 1	1/7/2021

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
Nutritrace Concentrate for solution for infusion	B.Braun Melsungen AG	SIN14341P	INFUSION, SOLUTION CONCENTRATE	0.166mg/10ml	4/22/2013
ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION	Fresenius Kabi Norge AS	SIN15302P	INFUSION, SOLUTION CONCENTRATE	16.6 mcg/ml	7/24/2017
PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION	FRESENIUS KABI NORGE AS	SIN08899P	INJECTION	1.31 mcg/ml	9/4/1996

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
JUNYELT CONCENTRATE FOR SOLUTION FOR INFUSION	N/A	HONG KONG MEDICAL SUPPLIES LIMITED	N/A	N/A	2/18/2019

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
THYRO-BLOCK potassium iodide 130mg tablet bottle	58351	Australian Nuclear Science and Technology Organisation T/A ANSTO	Medicine	A	5/21/1997
BLACKMORES SUPERKIDS MULTI CHEWABLES	289492	Blackmores Ltd	Medicine	A	5/30/2017
HKSG Swisse Kids Multi	321304	Swisse Wellness Pty Ltd	Medicine	A	8/5/2019
USANA HealthPak	350153	Usana Australia Pty Ltd	Medicine	A	11/30/2020
Supervite Multivitamin + Ginseng	312495	Mysekyo Australia Pty Ltd	Medicine	A	12/13/2018
Svelte	309025	Contract Manufacturing & Packaging Services Pty Ltd	Medicine	A	9/5/2018
METAGENICS ENERGYX TROPICAL FLAVOUR	343670	Metagenics (Aust) Pty Ltd	Medicine	A	9/17/2020
InNatal	346421	FIT-BioCeuticals Pty Ltd	Medicine	A	10/22/2020
Pro Saffron Mood	377510	The Better Health Company (Australia) PTY	Medicine	A	11/5/2021
Iodine Forte	356157	FIT-BioCeuticals Pty Ltd	Medicine	A	3/4/2021

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
TINCTURE OF IODINE	lawton's drug stores ltd.	00728683	Liquid - Topical	2.5 %	12/31/1987
TINCTURE OF IODINE 2.5%	rw consumer products ltd	00892084	Tincture - Topical	2.5 %	12/31/1995
NASAL SPRAY	botanical laboratories inc.	02233407	Liquid - Nasal	9 X	4/15/1998
METRATE	medic laboratory ltée	00230200	Syrup - Oral	20 MG / 5 ML	12/31/1963
THYROSAFE	recip ab	02247850	Tablet - Oral	65 MG	11/4/2003
SALZMANN PRODUCT B-2 BIASOLT	biocentre	00696420	Powder - Oral	5 X / X	12/31/1986
MULTI VITAMIN MINERAL TAB	nutristar health products (1987) inc.	00474800	Tablet - Oral	150 MCG / TAB	12/31/1979
KALIUM IODATUM GRANULE 1DH - 30CH	dolisos laboratoires s.a.	00698288	Tablet - Oral	1 DH / DH	12/31/1987
OSTEOHEEL HEEL-133 TAB	Biologische Heilmittel Heel Gmbh	01969080	Tablet - Oral	4 DH / TAB	12/31/1992
HOMEOPATHIC MEDICINE (S#171) DPS 30C	total health centre	02101971	Drops - Oral	30 C / ML	12/31/1994

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
PEDIAVEN G20 SOLUCION PARA PERFUSION	Fresenius Kabi España, S.A.U.	78951	SOLUCIÓN PARA PERFUSIÓN	Uso Hospitalario	Not Commercialized
LIDERVIT COMPRIMIDOS RECUBIERTOS CON PELICULA	Farmalider S.A.	83603	COMPRIMIDO RECUBIERTO CON PELÍCULA	Medicamento Sujeto A Prescripción Médica	Not Commercialized
YOFOLVIT 200/400/2 microgramos COMPRIMIDOS	Laboratorios Farmaceuticos Logogen S.A.	70192	COMPRIMIDO	Medicamento Sujeto A Prescripción Médica	Commercialized
ATOVIT COMPRIMIDOS RECUBIERTOS CON PELICULA	Farmalider S.A.	81982	COMPRIMIDO RECUBIERTO CON PELÍCULA	Medicamento Sujeto A Prescripción Médica	Not Commercialized
YODAFAR 200 microgramos COMPRIMIDOS	Laboratorios Bial S.A.	69596	COMPRIMIDO	Medicamento Sujeto A Prescripción Médica	Not Commercialized
INFUTRAZE CONCENTRADO PARA SOLUCION PARA PERFUSION	Fresenius Kabi España, S.A.U.	88927	CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN	Medicamento Sujeto A Prescripción Médica,Uso Hospitalario	Commercialized
YODAFAR 300 microgramos COMPRIMIDOS	Laboratorios Bial S.A.	69595	COMPRIMIDO	Medicamento Sujeto A Prescripción Médica	Not Commercialized
OLIGOPLUS CONCENTRADO PARA SOLUCION PARA PERFUSION	B. Braun Melsungen Ag	63781	CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN	Uso Hospitalario	Commercialized
YODUK COMPLEX COMPRIMIDOS	Casen Recordati S.L.	68852	COMPRIMIDO	Medicamento Sujeto A Prescripción Médica	Commercialized
YODUK 200 microgramos COMPRIMIDOS	Casen Recordati S.L.	66101	COMPRIMIDO	Medicamento Sujeto A Prescripción Médica	Commercialized

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access